Kabra Drugs Ltd

Kabra_Drugs10 Jun 2024
Pharmaceuticals
0.00 (0.00%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Kabra Drugs
Kabra Drugs Ltd
Pharmaceuticals
Kabra_Drugs10 Jun 2024
0.00 (0.00%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Kabra Drugs - Share Price & Details

Lowest Today
7.91
Highest Today
7.91
Today’s Open
7.91
Prev. Close
7.91
52 Week High
7.91
52 Week Low
3.18
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
46.48%
Upper Circuit
Lower Circuit
P/E TTM
0
P/B Ratio
3.22
Traded Value(Cr)
0.00
EPS TTM
0
Book value
Dividend
0.00%

Price Performance

4.91 %
1 Wk
4.91 %
1 M
15.47 %
3 M
46.48 %
1 Y
40.00 %
YTD

Traded Volume Movement

Technical Details

Support 3
0
Support 2
0
Support 1
0
Pivot Point :
0
Resistance 1
0
Resistance 2
0
Resistance 3
0

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Kabra Drugs Ltd
₹7.91(0.00/0.00%)
7.91+0.003.4746.480.003.22
Astrazeneca Pharma India Ltd
₹6,458.00(+107.05/1.69%)
6,458.00+107.0516,145.0076.98107.9922.68
Cipla Ltd
₹1,565.30(+21.85/1.42%)
1,565.30+21.85126,389.4859.9634.034.52
Bliss GVS Pharma Ltd
₹106.00(+0.65/0.62%)
106.00+0.651,109.7232.9314.641.12
Abbott India Ltd
₹27,452.30(-160.50/-0.58%)
27,452.30-160.5058,336.1424.2048.5615.77
Amrutanjan Health Care Ltd
₹749.85(-7.00/-0.92%)
749.85-7.002,167.8623.9748.197.51

About Kabra Drugs Ltd

Kabra Drugs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 3.47 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -0.37 crores for the quarter ended December 2018. The company management includes , B V Anatha Kumar,Ananthkumar Shilpa,Churchil Durai M Jebastine,KUNIAMUTHUR NANJAPPAN ANAND,Monika Sanwal,A Anitha (Kabra Drugs Ltd) among others.
Chairman
Registered office
270 Shastri Market Indore,,Indore,Madhya Pradesh,452007
FAX :
Background
Incorporation Year1989
Face Value₹10
Market Lot1

Latest News

Will Nifty touch 24,000 this week? Top 5 factors at play
The Nifty index remains within a narrow range of 23,200-23,500, with a potential breakout above 23,600 leading to a rally up to 24,000. Key factors influencing the market this week include ⏩Global markets, ⏩Macro cues, ⏩FII flow, ⏩Govt &⏩Technicals. Meanwhile, FII selling has reduced, & retail investors are eager to buy every dip, but FPIs may turn sellers again if the market rallies further.
16 Jun 2024 | 11:55 AM
Global Rate-Cut Juggernaut Is Struggling to Start
Central banks in the UK, Australia, Norway, and Switzerland are expected to keep interest rates on hold this week, with policymakers hesitant to cut rates due to lingering price pressures and uncertainty. The Bank of England is likely to wait until August to cut rates, while the Swiss National Bank may avoid a second rate reduction.
16 Jun 2024 | 04:37 PM
Infra stocks to continue their run beating capital goods shares
Domestic infrastructure and capital goods stocks have seen significant growth, with capital goods stocks tripling in value and infra stocks doubling over the past three years. The RBI has raised its GDP growth forecast to 7.2% for FY25, indicating a strong outlook for these sectors. Capital goods stocks have outperformed infra stocks due to lower capital requirements and stronger earnings.
16 Jun 2024 | 04:36 PM
Wipro wins multi-million dollar deal from Standard Chartered
Wipro Ltd has secured a major IT outsourcing contract from Standard Chartered Plc, marking its second significant win under CEO Srinivas Pallia. The financial terms of the deal were not disclosed, but the contract is expected to generate significant revenue for Wipro. This win is seen as a major boost to Wipro's growth prospects and a testament to Pallia's leadership.
16 Jun 2024 | 04:36 PM
Stocks to buy: Nykaa and Concor looking attractive, here's why
The Indian stock market is expected to remain positive in the short-term, with the Nifty range-bound between 23,300-23,500. Three stocks are recommended for buying:
📌Piramal Pharma Ltd: Buy at ₹157 | Target Price: ₹180/200 | Stop Loss: ₹150.
📌Nykaa: Buy at ₹170 | Target Price: ₹180/200 | Stop Loss: ₹160.
📌CONCOR: Buy at ₹1135 | Target Price: ₹1240/1360 | Stop Loss: ₹1060.
16 Jun 2024 | 04:34 PM

How to buy Kabra Drugs shares on nse?

To buy Kabra Drugs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Kabra Drugs share price today?

The Kabra Drugs shares price on nse is Rs.7.91 today.

What is the market cap of Kabra Drugs shares on BSE ?

The company has a market capitalization of Rs.3.47Cr

What is the PE & PB ratio of Kabra Drugs shares ?

PE is 0 and PB is 3.22

What is the 52 Week High and Low of Kabra Drugs shares?

Kabra Drugs stock price high: Rs.7.91 Kabra Drugs stock price low: Rs.3.18